9ED-40152-68254
2 vaccinations
2 coded responses
23 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 631 / MO
- Registered
- 2021-03-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-16
Registered in v-safe
-
2021-03-16
Dose 1 — Pfizer-BioNTech
- 2021-03-16
-
2021-03-17
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · None · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-18
- 2021-03-19
- 2021-03-21
- 2021-03-22
- 2021-03-23
- 2021-03-30
- 2021-04-06
-
2021-04-13
Dose 2 — Pfizer-BioNTech
- 2021-04-13
- 2021-04-14
- 2021-04-15
- 2021-04-17
- 2021-04-19
- 2021-04-20
- 2021-04-27
- 2021-05-04
- 2021-05-11
- 2021-05-20
- 2021-05-25
- 2021-07-13
-
2021-10-12
Survey response — 6 months, dose 2MedDRA: Autoimmune thyroiditis, Graves' disease — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Graves Disease and Hashimoto DiseaseMedDRA releases: 2024-11 · check-in free text available
-
2021-10-12
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2021-10-28
Call successfulParticipant prefers to complete VAERS report online
-
2022-04-15
Survey response — 12 months, dose 2MedDRA: Abortion spontaneous — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: MiscarriageMedDRA releases: 2024-11 · check-in free text available
-
2022-04-15
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-04-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-16 | Pfizer-BioNTech | |
| 2 | 2021-04-13 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-10-12 | Successful 2021-10-28 |
Participant prefers to complete VAERS report online |
| 2022-04-15 | Unsuccessful |
Free text
Release 10 — 6 months, dose 2
Symptoms: Graves Disease and Hashimoto Disease
Release 11 — 12 months, dose 2
Symptoms: Miscarriage
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | · | · | ✓ |
| SD | Autoimmune thyroiditis | · | · | ✓ |
| SD | Graves' disease | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release